Marmion M, Soro A, Whyte P, Scannell A
Heliyon. 2023; 9(7):e17655.
PMID: 37483745
PMC: 10362192.
DOI: 10.1016/j.heliyon.2023.e17655.
Kirit H, Bollback J, Lagator M
Mol Biol Evol. 2022; 39(11).
PMID: 36227733
PMC: 9641970.
DOI: 10.1093/molbev/msac220.
Le D, Krasnopeeva E, Sinjab F, Pilizota T, Kim M
mBio. 2021; 12(4):e0067621.
PMID: 34253054
PMC: 8406135.
DOI: 10.1128/mBio.00676-21.
Asmat U, Mumtaz M, Malik A
J Taibah Univ Med Sci. 2021; 16(1):102-111.
PMID: 33603638
PMC: 7858016.
DOI: 10.1016/j.jtumed.2020.10.010.
Sfera A, Osorio C, Diaz E, Maguire G, Cummings M
Front Endocrinol (Lausanne). 2020; 11:488.
PMID: 32849279
PMC: 7411001.
DOI: 10.3389/fendo.2020.00488.
New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria.
Spengler G, Kincses A, Gajdacs M, Amaral L
Molecules. 2017; 22(3).
PMID: 28294992
PMC: 6155429.
DOI: 10.3390/molecules22030468.
Role of Phenothiazines and Structurally Similar Compounds of Plant Origin in the Fight against Infections by Drug Resistant Bacteria.
Dastidar S, Kristiansen J, Molnar J, Amaral L
Antibiotics (Basel). 2016; 2(1):58-72.
PMID: 27029292
PMC: 4790298.
DOI: 10.3390/antibiotics2010058.
The ins and outs of RND efflux pumps in Escherichia coli.
Anes J, McCusker M, Fanning S, Martins M
Front Microbiol. 2015; 6:587.
PMID: 26113845
PMC: 4462101.
DOI: 10.3389/fmicb.2015.00587.
IS5 element integration, a novel mechanism for rapid in vivo emergence of tigecycline nonsusceptibility in Klebsiella pneumoniae.
Nielsen L, Snesrud E, Onmus-Leone F, Kwak Y, Aviles R, Steele E
Antimicrob Agents Chemother. 2014; 58(10):6151-6.
PMID: 25092708
PMC: 4187979.
DOI: 10.1128/AAC.03053-14.
Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them.
Amaral L, Martins A, Spengler G, Molnar J
Front Pharmacol. 2014; 4:168.
PMID: 24427138
PMC: 3879458.
DOI: 10.3389/fphar.2013.00168.
A Simple Method for Assessment of MDR Bacteria for Over-Expressed Efflux Pumps.
Martins M, McCusker M, Viveiros M, Couto I, Fanning S, Pages J
Open Microbiol J. 2013; 7:72-82.
PMID: 23589748
PMC: 3624690.
DOI: 10.2174/1874285801307010072.
Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation.
Kourtesi C, Ball A, Huang Y, Jachak S, Vera D, Khondkar P
Open Microbiol J. 2013; 7:34-52.
PMID: 23569468
PMC: 3617545.
DOI: 10.2174/1874285801307010034.
Mechanisms of resistance in bacteria: an evolutionary approach.
Martins A, Hunyadi A, Amaral L
Open Microbiol J. 2013; 7:53-8.
PMID: 23560029
PMC: 3613773.
DOI: 10.2174/1874285801307010053.
Antibiotic transport in resistant bacteria: synchrotron UV fluorescence microscopy to determine antibiotic accumulation with single cell resolution.
Kascakova S, Maigre L, Chevalier J, Refregiers M, Pages J
PLoS One. 2012; 7(6):e38624.
PMID: 22719907
PMC: 3373604.
DOI: 10.1371/journal.pone.0038624.
Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol.
Jeyaseeli L, Dasgupta A, Dastidar S, Molnar J, Amaral L
Eur J Clin Microbiol Infect Dis. 2011; 31(6):1243-50.
PMID: 21997771
DOI: 10.1007/s10096-011-1435-3.
Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.
Karczmarczyk M, Martins M, Quinn T, Leonard N, Fanning S
Appl Environ Microbiol. 2011; 77(20):7113-20.
PMID: 21856834
PMC: 3194846.
DOI: 10.1128/AEM.00600-11.
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
Nikaido H, Pages J
FEMS Microbiol Rev. 2011; 36(2):340-63.
PMID: 21707670
PMC: 3546547.
DOI: 10.1111/j.1574-6976.2011.00290.x.
